StockDrifts LogoStockDrifts

Jaysys Medical 287410

Company
제이시스메디칼Jaysys Medical
Insiders
7
Buys
2
Total Value
₩18.4B ($12.8M)
Avg Return
-1.98%
Last Filing
2024-10-23

Jaysys Medical (287410) has 2 disclosed insider purchases and 28 disclosed disposals on record, filed by 7 distinct insiders. Together those filings cover ₩18.4B ($12.8M) in reported transaction value. The earliest filing StockDrifts holds for Jaysys Medical is dated 2024-03-05; the most recent is 2024-10-23. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -1.98%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

No price data available

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2024-10-23BUY교환
시러큐스서브코
Syracuse Subco
-5.1M₩12,900+0.0%₩66.1B ($45.9M)
2024-08-22BUYMarket Buy
시러큐스서브코
Syracuse Subco
-298.6K₩12,830+0.6%₩3.8B ($2.7M)
2024-08-21BUYMarket Buy
시러큐스서브코
Syracuse Subco
-146.7K₩12,750+1.2%₩1.9B ($1.3M)
2024-08-16BUY공개매수
시러큐스서브코
Syracuse Subco
-7.2M₩12,920-0.1%₩92.6B ($64.3M)
2024-08-16SELL공개매수청약
이명훈
Myung-Hoon Lee
moving-753.6K₩12,920+0.1%₩9.7B ($6.8M)
2024-07-24BUY장외매수
시러큐스서브코
Syracuse Subco
-18.0M₩12,870+0.2%₩231.3B ($160.6M)
2024-07-24SELL장외매도
강동환
Donghwan Kang
Internal director-18.0M₩12,870-0.2%₩231.3B ($160.6M)
2024-07-24BUY공개매수
시러큐스서브코
Syracuse Subco
-42.5M₩12,870+0.2%₩547.0B ($379.8M)
2024-07-24BUY장외매수
시러큐스서브코
Syracuse Subco
-2.5M₩12,870+0.2%₩32.0B ($22.2M)
2024-07-24SELL장외매도
이명훈
Myung-Hoon Lee
moving-2.5M₩12,870-0.2%₩32.0B ($22.2M)
2024-07-18SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-20.0K₩12,920+0.1%₩258M ($179K)
2024-07-17SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-5.4K₩12,910+0.1%₩70M ($48K)
2024-07-17SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-87.2K₩12,910+0.1%₩1.1B ($781K)
2024-07-16SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-13.2K₩12,910+0.1%₩170M ($118K)
2024-07-10SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-80.0K₩12,900+0.0%₩1.0B ($717K)
2024-07-09SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-70.0K₩12,900+0.0%₩903M ($627K)
2024-07-08SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-50.0K₩12,900+0.0%₩645M ($448K)
2024-07-08SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-5.6K₩12,900+0.0%₩72M ($50K)
2024-07-05SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-546₩12,890-0.1%₩7M ($5K)
2024-07-05SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-20.0K₩12,890-0.1%₩258M ($179K)
2024-07-04SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-10.0K₩12,890-0.1%₩129M ($90K)
2024-07-03SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-50.0K₩12,880-0.2%₩644M ($447K)
2024-07-03SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-50.0K₩12,880-0.2%₩644M ($447K)
2024-07-03SELLMarket Sell
이명훈
Myung-Hoon Lee
moving-37.6K₩12,880-0.2%₩485M ($337K)
2024-07-01SELLMarket Sell
강일권
Kang Il-kwon
Managing Director-2.0K₩12,890-0.1%₩26M ($18K)
2024-06-25SELLMarket Sell
안병석
Byeongseok Ahn
moving-23.0K₩12,860-0.3%₩296M ($205K)
2024-06-20SELLMarket Sell
선혜진
Hyejin Seon
moving-20.1K₩12,860-0.3%₩258M ($179K)
2024-06-18SELLMarket Sell
선혜진
Hyejin Seon
moving-50.0K₩12,830-0.6%₩642M ($445K)
2024-06-18SELLMarket Sell
선혜진
Hyejin Seon
moving-50.0K₩12,830-0.6%₩642M ($445K)
2024-06-14SELLMarket Sell
선혜진
Hyejin Seon
moving-11.7K₩12,800-0.8%₩150M ($104K)
2024-06-14SELLMarket Sell
김민영
Minyoung Kim
Managing Director-135.7K₩12,800-0.8%₩1.7B ($1.2M)
2024-06-12SELLMarket Sell
김민영
Minyoung Kim
Managing Director-17.2K₩12,790-0.9%₩220M ($153K)
2024-06-12SELLMarket Sell
YI WON JU
torture-25.0K₩12,790-0.9%₩320M ($222K)
2024-06-12SELLMarket Sell
YI WON JU
torture-24.7K₩12,790-0.9%₩316M ($219K)
2024-05-28SELLMarket Sell
YI WON JU
torture-1.2K₩11,660-10.6%₩14M ($10K)
2024-05-23SELLMarket Sell
YI WON JU
torture-5.0K₩12,030-7.2%₩60M ($42K)
2024-05-20SELLMarket Sell
선혜진
Hyejin Seon
moving-10.0K₩11,770-9.6%₩118M ($82K)
2024-04-23SELLMarket Sell
김민영
Minyoung Kim
Managing Director-143.0K₩10,120-27.5%₩1.4B ($1.0M)
2024-03-31SELL임원퇴임
김태환
Taehwan Kim
Managing Director-305.9K₩8,930-44.5%₩2.7B ($1.9M)
2024-03-05BUY주식매수청구권 행사
김민영
Minyoung Kim
Managing Director25.0K₩7,910+63.1%₩198M ($137K)
2024-03-05BUY주식매수청구권 행사
안병석
Byeongseok Ahn
moving23.0K₩7,910+63.1%₩182M ($126K)

Frequently asked questions

Who has been buying Jaysys Medical stock?
7 distinct insiders have filed 2 disclosed insider purchases in Jaysys Medical (287410), most recently on 2024-10-23. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Jaysys Medical have?
Jaysys Medical has 2 buy-side and 28 sell-side disclosures on record, covering ₩18.4B ($12.8M) in total reported value, spanning 2024-03-05 to 2024-10-23.
Where does StockDrifts get Jaysys Medical insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Jaysys Medical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.